--- title: 'Vice President, U.S. Market Access & Pricing at Vaxcyte' canonical: 'https://feeny.ai/job/vice-president-u-s-market-access-pricing-vaxcyte-san-carlos-california-4dhwzchd08rv' type: 'job' last_seen: '2026-09-14' --- # Vice President, U.S. Market Access & Pricing at Vaxcyte - **Company:** Vaxcyte - **Location:** San Carlos California, United States - **Posted:** 2026-06-04 - **Last confirmed live:** 2026-09-14 - **Apply:** https://boards.greenhouse.io/vaxcyte/jobs/5236929008?gh_jid=5236929008 ## Job description Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE:  The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Vice President, Market Access will lead the strategy and execution of all market access activities to support the successful launch of the company’s adult pneumococcal vaccine. Reporting to the Chief Commercial Officer, this role will be accountable for ensuring broad, timely, and sustainable access across public and private channels. As Vaxcyte prepares for its first commercial launch, the VP will operate as a hands-on leader, building foundational capabilities while directly shaping payer, provider, and policy environments. This role requires a balance of strategic leadership and execution, with a particular focus on navigating the unique access dynamics of adult vaccines, including public health recommendations, buy-and-bill reimbursement, and site-of-care considerations. Essential Functions: - Lead development and execution of the U.S. market access strategy for the adult pneumococcal vaccine, including pricing, reimbursement, contracting, and channel strategy - Define and drive launch readiness plans aligned to regulatory approval and immunization guideline milestones (e.g., ACIP or other recommending bodies) - Shape access strategies across commercial payers, Medicare, Medicaid, and public health channels - Develop and execute engagement strategies for key stakeholders, including GPOs, IDNs, retail pharmacy, and public health entities - Establish pricing strategy and gross-to-net assumptions, ensuring alignment with vaccine-specific market dynamics - Ensure readiness for coding, coverage, reimbursement, and provider economics within buy-and-bill and pharmacy settings - Partner with Medical Affairs to define and deliver HEOR and value evidence to support payer and policy decision-making - Serve as the market access lead across cross-functional teams, aligning with Commercial, Medical, Regulatory, Government Affairs, and Finance - Build and lead a lean market access function, leveraging external partners to scale capabilities efficiently - Working cross functionally, prepare for CDC immunization program, state immunization program, and ACIP-adjacent policy stakeholder engagements; translate ACIP recommendation language into access and coverage implications across all channels - Develop and execute integrated PBM, commercial payer, and Medicare Part B and D contracting strategies to ensure optimal formulary positioning, coverage, and patient access across channels. - Support development of national retail pharmacy and alternate vaccination site strategies, establishing partnerships that maximize vaccine availability, administration, and uptake. - Develop scenario-based access, reimbursement, and customer adoption strategies aligned to potential ACIP recommendation outcomes and evolving adult immunization guidelines Requirements: - Bachelor’s degree required; advanced degree (MBA, MPH, PharmD, PhD) preferred - 15+ years of experience in market access, pricing, reimbursement, or related functions within biotech/pharma - Demonstrated experience supporting or leading product launches, ideally in vaccines, infectious disease, or buy-and-bill products - Strong understanding of adult vaccine access dynamics, including public health recommendations, Medicare Part B and Part D reimbursement, Medicaid, 340B program implications, CDC contract vehicles (Section 317 and VFC), and site-of-care economics - Experience operating in lean or pre-commercial biotech environments, with a demonstrated track record of building market access capabilities from the ground up - Proven ability to balance strategic thinking with hands-on execution - Strong cross-functional leadership and stakeholder influence skills - Experience managing gross-to-net financial modelling, including rebate strategy across payers - Demonstrated ability to work collaboratively with HEOR teams to translate cost-effectiveness models, budget impact analyses, and payer value dossiers into P&T committee submissions or ICER reviews - Prior engagement with CDC immunization programs, state immunization programs, or ACIP-adjacent policy processes; understanding of how ACIP recommendation language drives uptake across channels Reports to: Chief Commercial Officer Location: East Coast - US Work Arrangement: Hybrid (minimum of 2-3 days per week) / Remote Compensation: The compensation package will be competitive and includes comprehensive benefits and an equity component. Salary Range: $333,000 - $388,000 (SF Bay Area). Salary ranges for non-California locations may vary. Relocation: This role is eligible for relocation assistance. ## Equal Opportunity We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status. Recruitment Fraud Notice Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent Vaxcyte in recruitment activities. Vaxcyte has an established recruitment process for all positions prior to issuing an offer for employment and we will never extend unsolicited employment offers or ask candidates to provide financial or sensitive personal information as part of the application process. All legitimate communication from Vaxcyte will come from an official @vaxcyte.com email address. Qualified and interested candidates should apply to current openings at [vaxcyte.com/careers](https://vaxcyte.com/careers/). ## About Vaxcyte ## Company Overview - **One-liner**: Vaxcyte is a clinical-stage biotechnology company re-engineering how vaccines are made to eliminate bacterial infections, using a cell-free protein synthesis platform to develop high-fidelity, broad-spectrum vaccines. - **Entity Type**: Public (Ticker: PCVX) - **Headquarters**: San Carlos, California, United States - **Founded**: 2013 (as SutroVax; rebranded to Vaxcyte in 2020) - **Founders**: Not publicly available (the company emerged from Sutro Biopharma’s spin-out) ## Core Business - **Primary industry**: Biotechnology / Vaccines (Infectious Disease) - **Target customers**: Global healthcare systems, public health organizations, and ultimately patients (B2B/Institutional); the company develops vaccines for both pediatric and adult populations. - **Mission or purpose**: To protect humankind from the consequences of bacterial infections, eliminating diseases like invasive pneumococcal disease, Group A Strep, and Shigella. ## Products & Services - **VAX-31 (31-valent PCV)**: A broad-spectrum pneumococcal conjugate vaccine candidate in Phase 3 for adults and Phase 2 for infants. Designed to cover over 95% of circulating IPD serotypes in U.S. adults 50+ and ~94% in infants. FDA Breakthrough Therapy designation granted. - **VAX-24 (24-valent PCV)**: A pneumococcal conjugate vaccine candidate in Phase 2 for infants, designed to cover more serotypes than any infant PCV on the market today. - **VAX-A1 (Group A Strep)**: A preclinical conjugate vaccine candidate for Group A Strep, a disease with no currently approved vaccine. Phase 1 first-in-human study (adults) underway in Australia. - **VAX-GI (Shigella)**: A novel preclinical vaccine candidate targeting Shigella, a leading cause of diarrheal disease. - **Platform Technology**: A proprietary cell-free protein synthesis platform that enables site-specific, carrier-sparing conjugation to produce precisely targeted vaccines with enhanced immunogenicity. ## Market Standing - **Valuation/Market Cap**: ~$16.7 billion (as of early July 2026) - **Key Metric**: Total funding raised (private) is not applicable; as a public company, key metrics include cash position (~$2.0 billion as of Q1 2026) and R&D investment. The company is pre-revenue. - **Notable Investors/Partners**: Major institutional investors include Baker Bros. Advisors, Fidelity, and funds managed by BlackRock. Key partnership: exclusive license agreement with Sutro Biopharma for its cell-free protein synthesis platform. - **Growth Signals**: - Up to $1 billion commitment to expanding U.S. manufacturing with a new facility in North Carolina. - VAX-31 Phase 3 program (OPUS-1, OPUS-2, OPUS-3) topline data expected Q4 2026 – H1 2027. - Headcount growth: actively hiring across 100+ roles (Analytical, Commercial, Clinical, Conjugation, Quality, Regulatory). - Recognized as a Great Place to Work and Best Workplace in BioPharma (multiple years). ## Competitive Advantages - **Broadest-spectrum PCV candidates**: VAX-31 is the broadest-spectrum pneumococcal conjugate vaccine in the clinic, targeting up to 31 serotypes. - **Differentiated platform**: Cell-free protein synthesis allows for the creation of complex, high-fidelity vaccines that can overcome bacterial defense mechanisms (e.g., capsule-switching) that limit conventional cell-based vaccines. - **Carrier-sparing technology**: Site-specific conjugation enables a higher valency (more serotypes) without compromising immunogenicity or tolerability. - **Manufacturing scale**: Significant investment in U.S.-based production capacity provides a long-term supply chain advantage and aligns with "Investing in America" initiatives. ## Strategic Focus - **Primary**: Advance VAX-31 and VAX-24 through late-stage clinical trials to secure regulatory approval and establish a new standard of care for pneumococcal disease. - **Pipeline expansion**: Advance VAX-A1 (Group A Strep) and VAX-GI (Shigella) candidates through early clinical development. - **Manufacturing**: Scale up internal manufacturing capabilities to support commercial launch and global supply. - **Commercial readiness**: Building a commercial organization (e.g., hiring a VP of U.S. Market Access & Pricing, Senior Director of Product Launch) to prepare for potential VAX-31 launch. ## Why Work Here - **Culture**: Described as a "kindness-first" mindset with a focus on audacious goals, collaboration, and mutual support. Recognized as a *Great Place to Work* and *Best Workplace in BioPharma* (Fortune). - **Work Model**: Hybrid, Remote, and Onsite options available depending on role. San Carlos HQ offers a hybrid schedule. - **Total Rewards**: 100% paid health, dental, and vision insurance; 401k matching; flexible PTO and holidays; paid parental and sick leave; equity awards (stock options & RSUs); Employee Stock Purchase Plan; lifestyle spending account; mental health and wellness resources. - **Growth & Development**: Strong emphasis on learning culture, professional advancement through coaching, and career development programs. - **Mission-driven**: Employees are directly contributing to creating vaccines that protect every child born and every adult at risk from bacterial infections globally. ## Sources 1. [vaxcyte.com](https://vaxcyte.com/) 2. [vaxcyte.com/careers](https://vaxcyte.com/careers/) 3. [vaxcyte.com/job-listings](https://vaxcyte.com/job-listings/) 4. [vaxcyte.com/culture](https://vaxcyte.com/culture/) 5. [vaxcyte.com/pipeline](https://vaxcyte.com/pipeline/) ## Other roles at Vaxcyte - [Senior Bioprocess Engineer II, MSAT, Proteins](https://feeny.ai/job/senior-bioprocess-engineer-ii-msat-proteins-vaxcyte-visp-valais-sfkyafmqg7tb) — Visp Valais, Switzerland - [Commercial Project Manager](https://feeny.ai/job/commercial-project-manager-vaxcyte-san-carlos-california-yh8r45mh59a6) — San Carlos California, United States - [Scientist II, Analytical Development (Contract)](https://feeny.ai/job/scientist-ii-analytical-development-contract-vaxcyte-san-carlos-california-b83zc60zvhs3) — San Carlos California, United States - [Lab Compliance Manager](https://feeny.ai/job/lab-compliance-manager-vaxcyte-san-carlos-california-znaqawfbg3r6) — San Carlos California, United States - [Staff Engineer, Process Development and Manufacturing](https://feeny.ai/job/staff-engineer-process-development-and-manufacturing-vaxcyte-san-carlos-bhp8b915gpmn) — San Carlos California, United States - [Manager, Supplier & Internal Auditor](https://feeny.ai/job/manager-supplier-internal-auditor-vaxcyte-san-carlos-california-zshqy3z2ptnp) — San Carlos California, United States - [Senior Manager, Immunoassay Development](https://feeny.ai/job/senior-manager-immunoassay-development-vaxcyte-san-carlos-california-w23kqwk0742d) — San Carlos California, United States - [Lab Manager, Immunoassay Development](https://feeny.ai/job/lab-manager-immunoassay-development-vaxcyte-san-carlos-california-hhgxc5d71egf) — San Carlos California, United States - [Associate Scientist II, Immunoassay Development](https://feeny.ai/job/associate-scientist-ii-immunoassay-development-vaxcyte-san-carlos-california-ems6zhtbe7aj) — San Carlos California, United States - [Scientist, Immunoassay Development](https://feeny.ai/job/scientist-immunoassay-development-vaxcyte-san-carlos-california-datkfkv3dcne) — San Carlos California, United States